Syngene has made two significant investments recently — in peptide synthesis and ADC bioconjugation. What do these moves say ...

Eli Lilly and J&J recently announced partnerships with AI chipmaker Nvidia, pointing to a broader trend of tie-ups to advance ...

Collaboration set to enhance peptide discovery for challenging GPCR targets and advancing research across multiple therapeutic areas. [Glasgow, UK – 19 November 2025] – BioAscent, a leading provider ...

The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical manufacturing.

Aspida Financial, a life insurance company, and medicine manufacturer Novartis Gene Therapies are bringing more than 1,000 ...

The company expects to create 700 new jobs by the end of 2030 in Durham and Wake counties. That will be on top of a $771 ...

The Swiss pharmaceutical firm is the third company this week to announce a major investment in North Carolina, part of a wave ...

The Swiss pharmaceutical company says it will nearly double area footprint at locations in Durham and Morrisville.

Novartis plans to upfit a 202,000-square-foot purpose-built space in Pathway Triangle, a new advanced manufacturing campus in ...

Located in Liverpool’s Knowledge Quarter, it is hoped that the new AI Materials Hub for Innovation (Aim-Hi) will be a ...

Earlier this year, biotechnology company Biomar filed for voluntary bankruptcy proceedings. The company was one of the first institutions to establish itself in the Léon Technology Park in Monterrey, ...